glp-1 receptor agonists cardiovascular benefits in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Mechanisms of action and effects

Incretins are gut secreted hormones, G-protein-coupled receptor peptides, that include glucagon-like peptide 1 (GLP-1), gastric inhibitory polypeptide (GIP) and glucagon (GCG)

That cross-substance signal points to a shared biology underlying addiction, and it opens the door to a fundamentally different approach: not treating one addiction at a time, but targeting that common biologic signal, that common craving across addictions

She thinks there are also likely financial and accessibility issues at play

If satiety effects persist despite stalled weight loss, the medication is working

Conversion charts are helpful for safely switching between GLP-1 medications

In mice and non-human primates, dual GLP-1R/GCGR (glucagon receptor) agonists have been shown to induce excellent glycemic control and significantly greater weight loss than liraglutide monotherapy, increasing energy expenditure and reducing total energy intake by 6070% [158]